Overview
Details
Chat
Eli Lilly and Company (LLY.US) 1Q 2022 Earnings Call
Live streaming time: 28/04/2022 13:00
Eli Lilly and Company specializes in the discovery, development, manufacturing, and sales of pharmaceutical products. Its products include therapies for diabetes, oncology, immunology, neuroscience, and other areas. Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. Oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Immunology products include Olumiant and Taltz. Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly and Company in May 1876 and is headquartered in Indianapolis.
Live Assistant
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.